Researcher
Jozef Van Damme
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Immunology
Affiliations
- Molecular Immunology (Rega Institute) (Lab)
Member
From1 Oct 1999 → Today
Projects
1 - 6 of 6
- Wound healing in diabetes with innate immune molecules and cellsFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- The biology of modified chemokines in acute inflammation.From1 Sep 2013 → 31 Aug 2018Funding: International Cooperation and Mobility
- Innate immune mechanisms in infection, inflammation and cancer.From1 Jan 2013 → 31 Dec 2017Funding: BOF - Concerted Research Project from 1994
- The role of synergy and antagonisation between chemokine variants in immunity and cancerFrom1 Jan 2013 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Structural and functional comparisons of MMP-9 formsFrom1 Oct 2009 → 21 Nov 2013Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of post-translational modification of chemokines in inflammation and angiogenesis.From1 Jan 2009 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 145
- Matrix metalloproteinases in arthritis: towards precision medicine(2023)
Authors: Jo Van Damme, Paul Proost, Ghislain Opdenakker
Pages: 363 - 377 - Antibodies as tools in cytokine discovery and usage for diagnosis and therapy of inflammatory diseases.(2023)
Authors: Jo Van Damme, Ghislain Opdenakker, Sofie Struyf
Pages: 1 - 9 - Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands(2023)
Authors: Sara Salama, Mieke Gouwy, Jo Van Damme, Sofie Struyf
Pages: 1 - 15 - Efficacy of B Cell Depletion Therapy with Rituximab in Refractory Chronic Recurrent Uveitis Associated with Vogt-Koyanagi-Harada Disease(2022)
Authors: Sofie Struyf, Jo Van Damme, Ghislain Opdenakker
Pages: 750 - 757 - Chlorite-Oxidized Oxyamylose (COAM) Has Antibacterial Activity and Positively Affects Skin Wound Healing(2022)
Authors: Jennifer Vandooren, Jo Van Damme, Jan Vranckx, Patrick Matthys, Ghislain Opdenakker
Pages: 4995 - 5008 - Inhibition of renal fibrosis with a human CXCL9-derived glycosaminoglycan-binding peptide(2022)
Authors: Helena Crijns, Alexandra De Zutter, Maarten Albersen, Ghislain Opdenakker, Jo Van Damme, Ben Sprangers, Paul Proost, Sofie Struyf
- Proteoform Analysis of Matrix Metalloproteinase-9/Gelatinase B and Discovery of Its Citrullination in Rheumatoid Arthritis Synovial Fluids(2021)
Authors: Karen Yu, Lise Boon, Jennifer Vandooren, Patrick Verschueren, Jo Van Damme, Paul Proost, Ghislain Opdenakker
- New Perspectives on the Immunopathogenesis and Treatment of Uveitis Associated With Vogt-Koyanagi-Harada Disease(2021)
Authors: Jo Van Damme, Sofie Struyf, Ghislain Opdenakker
- The Chemokine-Based Peptide, CXCL9(74-103), Inhibits Angiogenesis by Blocking Heparan Sulfate Proteoglycan-Mediated Signaling of Multiple Endothelial Growth Factors(2021)
Authors: Alexandra De Zutter, Helena Crijns, Paulien Verscheure, Peter Carmeliet, Jo Van Damme, Paul Proost, Sofie Struyf
- The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer(2021)
Authors: Alexandra De Zutter, Jo Van Damme, Sofie Struyf